
NYSEHealthcareMedical - Instruments & Supplies
最新データ
$125.12
+$0.93 · +0.75%
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
前日終値
$125.12
+$0.93 · +0.75%
日中の時刻はETです。市場データは遅延する場合があります。
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
日中レンジ
現在 $125.12
52週レンジ
現在 $125.12
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
54
適正価値
センチメント
68
強気
リスク
24
中程度のリスク
モメンタム
50
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
日中レンジ
現在 $125.12
52週レンジ
現在 $125.12
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 19.93億 USD | 30.47億 USD | 29.74億 USD | 27.91億 USD | 28.1億 USD |
| 売上原価 | 8.72億 USD | 13.45億 USD | 13.28億 USD | 12.6億 USD | 12.6億 USD |
| 粗利益 | 11.21億 USD | 17.03億 USD | 16.47億 USD | 15.31億 USD | 15.5億 USD |
| 研究開発 | 1.45億 USD | 1.62億 USD | 1.54億 USD | 1.54億 USD | 1.31億 USD |
| 販売・一般管理 | 7.2億 USD | 9.95億 USD | 9.3億 USD | 8.64億 USD | 8.6億 USD |
| 営業費用 | 8.65億 USD | 15.52億 USD | 11.41億 USD | 10.31億 USD | 9.22億 USD |
| 受取利息 | 640.3万 USD | 800.9万 USD | 1278.1万 USD | 91.2万 USD | 132.8万 USD |
| 支払利息 | 1億 USD | 8354.4万 USD | 8508.2万 USD | 5426.4万 USD | 5696.9万 USD |
| 減価償却費と償却費 | 1.78億 USD | 2.75億 USD | 2.42億 USD | 2.31億 USD | 2.37億 USD |
| 営業利益 | 2.56億 USD | 1.51億 USD | 5.06億 USD | 5億 USD | 6.28億 USD |
| 純利益 | −9.06億 USD | 6967.5万 USD | 3.56億 USD | 3.63億 USD | 4.85億 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$155.25
上昇余地(24.08%)分割調整後の1株当たりの年間現金分配金。
$1.36
2025年(通年)0.0% 以来 2021
2026年(一部):$1.02
$1.36
2,021
$1.36
2,022
$1.36
2,023
$1.36
2,024
$1.36
2,025
$1.02
2,026*
* 利用可能な配当履歴のうち、暦年の一部のみを含みます。
| 種別 | 配当落ち日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
配当 | 2026年8月14日 | $0.34Quarterly | 2026年8月14日 | 2026年9月30日 |
配当 | 2026年5月22日 | $0.34Quarterly | 2026年5月25日 | 2026年6月30日 |
配当 | 2026年3月6日 | $0.34Quarterly | 2026年3月6日 | 2026年3月31日 |
配当 | 2025年11月14日 | $0.34Quarterly | 2025年11月14日 | 2025年12月15日 |
配当 | 2025年8月15日 | $0.34Quarterly | 2025年8月15日 | 2025年9月15日 |
配当 | 2025年5月20日 | $0.34Quarterly | 2025年5月20日 | 2025年6月16日 |
配当落ち 2026年8月14日
$0.34
Quarterly
2026年8月14日基準 · 支払日 2026年9月30日
配当落ち 2026年5月22日
$0.34
Quarterly
2026年5月25日基準 · 支払日 2026年6月30日
配当落ち 2026年3月6日
$0.34
Quarterly
2026年3月6日基準 · 支払日 2026年3月31日
配当落ち 2025年11月14日
$0.34
Quarterly
2025年11月14日基準 · 支払日 2025年12月15日
配当落ち 2025年8月15日
$0.34
Quarterly
2025年8月15日基準 · 支払日 2025年9月15日
配当落ち 2025年5月20日
$0.34
Quarterly
2025年5月20日基準 · 支払日 2025年6月16日
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2億0.01%2.3兆 USD0.03%$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB1.45億0.08%1853億 USD0.03%$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR9189.03万0.13%682億 USD0.05%$234.43+0.22%
Vanguard Extended Market ETFVXF7307.82万0.08%954億 USD0.05%$235+0.80%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM4826.38万0.30%158.4億 USD0.03%$53.45+0.17%
Dimensional - US Small Cap ETFDFAS4286.17万0.13%338.69億 USD0.31%$78.35+0.32%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV4079.19万0.15%268.09億 USD0.33%$37.95-0.39%
Schwab U.S. Small-Cap ETFSCHA2795.61万0.13%218.24億 USD0.03%$32.79+0.40%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Dimensional - US Small Cap ETFDFAS
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Schwab U.S. Small-Cap ETFSCHAAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。